-
AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) shares
jumped 85.5 percent to $1.35 after the company reported positive CHMP opinion for tivozanib for the treatment of advanced renal
cell carcinoma.
-
Synchronoss Technologies, Inc. (NASDAQ: SNCR)
surged 34.7 percent to $16.40. Siris Capital believes it is in a position to buy Synchronoss at $18 per share in cash.
-
Root9B Holdings Inc (NASDAQ: RTNB) shares rose
17.4 percent to $8.23.
-
Cara Therapeutics Inc (NASDAQ: CARA) shares
climbed 17.1 percent to $23.27 after the company disclosed that it has received Breakthrough Therapy designation for IV CR845
for the treatment of chronic kidney disease-associated pruritus in hemodialysis patients.
-
Finish Line Inc (NASDAQ: FINL) shares gained 9.1
percent to $13.89. Finish Line reported in-line earnings for its first quarter, while sales missed estimates.
-
Amyris Inc (NASDAQ: AMRS) shares rose 8.8 percent
to $3.58.
-
Barnes & Noble, Inc. (NYSE: BKS) shares surged 8.6
percent to $7.60. Barnes & Noble reported a narrower-than-expected loss for its fourth quarter on Thursday.
-
Aware, Inc. (NASDAQ: AWRE) shares gained 9.5
percent to $5.20.
-
AdvanSix Inc (NYSE: ASIX) climbed 7.6 percent to
$32.30. Cowen & Co. initiated coverage on AdvanSix with an Outperform rating.
-
Forestar Group Inc. (NYSE: FOR) rose 5.8 percent to
$17.45. D.R. Horton, Inc. (NYSE: DHI)
raised its bid to acquire Forestar to $17.75 per share.
-
Stemline Therapeutics Inc (NASDAQ: STML) gained
5.6 percent to $8.98. Stemline Therapeutics presented SL-401 updated Stage 1 and 2 data from ongoing pivotal trial in BPDCN.
-
Antares Pharma Inc (NASDAQ: ATRS) jumped 5.3
percent to $3.17. H.C. Wainwright initiated coverage of Antares Pharma with a Buy rating.
-
RH (NYSE: RH) climbed 4.9 percent to $59.41. Deutsche
Bank upgraded RH fom Hold to Buy.
-
AK Steel Holding Corporation (NYSE: AKS) shares
gained 4.2 percent to $6.56. Deutsche Bank upgraded AK Steel from Hold to Buy.
-
United States Steel Corporation (NYSE: X) shares rose
4 percent to $21.91. Deutsche Bank upgraded United States Steel from Hold to Buy.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.